False Rumors Threaten Bangladesh's Typhoid Vaccination Campaign
In a shocking revelation, a UNICEF health manager has exposed how misinformation about typhoid vaccines is hindering a critical nationwide effort to protect children in Bangladesh from this deadly disease. The disinformation, spread through social media, claims that the typhoid vaccine injects the disease-causing germ into the body, a notion that is not only misleading but also dangerous. However, the truth is that the vaccine employs a non-risk virus, engineered to mimic the typhoid-causing bacteria, to stimulate the body's antibody production.
A viral Facebook post in Bengali, shared over 3,000 times, urged parents to keep their children away from the vaccine, stating, "I would request parents, do not let enter your beloved child's body at all. Stay away from these." The post further questioned the vaccine's side effects and the need for vaccination when a cure for typhoid fever exists. This misinformation campaign emerged just as the Bangladesh government initiated a drive to vaccinate approximately 50 million children aged 9 months to under 15 years against typhoid fever, a preventable disease caused by the Salmonella typhi bacteria.
Bangladesh has a commendable history of successful vaccination campaigns, such as the polio drive that led to the country being certified virus-free in 2014. In 2024, they achieved a remarkable 93% inoculation rate among eligible girls against the human papillomavirus (HPV), which can cause cervical cancer. However, the recent false claims about the Typhibev typhoid conjugate vaccine have sparked fears and skepticism among the public.
One concerned user commented, "If this is the case, then why don't the government ban it officially? Don't confuse the common people again." Another individual claimed that no one in their family had received the vaccine. These comments highlight the impact of misinformation on public perception and trust in vaccination programs.
Riad Mahmud, a UNICEF health manager involved in the campaign, confirmed that the disinformation has indeed slowed down the vaccination drive, particularly in urban areas. In the capital Dhaka, the vaccination rate was 70%, significantly lower than the 85% achieved in rural regions. Mahmud attributed this disparity to the negative social media campaigns, which have confused many parents.
Despite the misinformation, the Typhibev vaccine has been endorsed by the World Health Organization (WHO) as safe and effective. The WHO's Public Assessment Report states that the vaccine's safety profile is satisfactory. Furthermore, infectious diseases expert Dr. Tajul Islam Bari reiterated that the vaccine does not contain the Salmonella typhi bacteria but uses the non-risk virus Citrobacter freundii to trigger an immune response.
Dr. Bari also emphasized the necessity of typhoid vaccinations, explaining that the virus has mutated due to our modern lifestyle and increased antibiotic resistance. This mutation renders oral medications less effective in many cases. The vaccine's potential side effects, as outlined in the WHO's package insert, include injection site pain, swelling, and redness, as well as general fatigue and fever.
This is not the first time that false claims have threatened vaccination drives. AFP has previously debunked similar misinformation, but the persistence of these rumors continues to pose a challenge to public health initiatives. The question remains: how can we effectively combat misinformation and ensure that life-saving vaccines reach those who need them most?
